Literature DB >> 26591121

Study of Clinical Profile of Patients of Non Alcoholic Fatty Liver Disease and its Association with Metabolic Syndrome.

Rakesh Gaharwar, Sushma Trikha, Shubha Laxmi Margekar, Om Prakash Jatav, P Deepak Ganga.   

Abstract

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is considered to be the commonest liver problem in the western world and is increasingly being recognised as a major cause of liver-related morbidity and mortality. It is known to be associated with various metabolic abnormalities, but not much information regarding association between the metabolic disease and the severity of fatty liver is available. AIMS: To study the clinical profile of patients of NAFLD with varying degrees of severity as diagnosed by ultrasonography and to study the correlation between the non-alcoholic fatty liver disease and metabolic syndrome along with its individual components.
MATERIAL AND METHODS: The study was an observational and analytical study of patients diagnosed as NAFLD, attending OPD and indoor patients of the Department of Medicine, J A Group of hospitals. All patients diagnosed as NAFLD were investigated for metabolic syndrome according to the NCEP ATP 3 Criteria and a relationship between NAFLD and metabolic syndrome was studied.
RESULTS: 51.4% of patients of NAFLD had metabolic syndrome and statistical significance was found in AST, diabetes mellitus and lipid profile.
CONCLUSIONS: There is higher prevalence of all the components of metabolic syndrome in cases of NAFLD. Its early detection will help in modifying the disease course, delaying complications and will also play a major role in preventive cardiology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26591121

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  2 in total

1.  The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial.

Authors:  Milad Daneshi-Maskooni; Seyed Ali Keshavarz; Siavash Mansouri; Mostafa Qorbani; Seyed Moayed Alavian; Mahtab Badri-Fariman; Seyed Ali Jazayeri-Tehrani; Gity Sotoudeh
Journal:  Trials       Date:  2017-06-07       Impact factor: 2.279

2.  Green cardamom increases Sirtuin-1 and reduces inflammation in overweight or obese patients with non-alcoholic fatty liver disease: a double-blind randomized placebo-controlled clinical trial.

Authors:  Milad Daneshi-Maskooni; Seyed Ali Keshavarz; Mostafa Qorbani; Siavash Mansouri; Seyed Moayed Alavian; Mahtab Badri-Fariman; Seyed Ali Jazayeri-Tehrani; Gity Sotoudeh
Journal:  Nutr Metab (Lond)       Date:  2018-09-25       Impact factor: 4.169

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.